CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

• Status: Completed
• Trial end date: 2004-07-01

Summary

To compare a stable dose of salmeterol/fluticasone propionate with a variable dose of formoterol/budesonide where the dose is adjusted according to a physician-guided self-management plan

• Phase: Phase 4

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Budesonide; Fluticasone; Formoterol Fumarate; Salmeterol Xinafoate; Xhance